Quick Answer
ABVC BIOPHARMA, INC. reported Total Assets of $21.06 million for fiscal year 2025.
ABVC BIOPHARMA, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.06M | +179.3% |
| 2024 | $7.54M | -3.1% |
| 2023 | $7.78M | -18.7% |
| 2022 | $9.58M | -30.1% |
| 2021 | $13.70M | +18.0% |
| 2020 | $11.61M | +67.5% |
| 2019 | $6.93M | +16.6% |
| 2018 | $5.94M | +124.7% |
| 2017 | $2.64M | -4.0% |
| 2017 | $2.75M | +1453.3% |
| 2016 | $177.4K | -82.3% |
| 2015 | $1.00M | +1433.1% |
| 2014 | $65.4K | -71.8% |
| 2013 | $232.0K | -23.3% |
| 2012 | $302.3K | -18.2% |
| 2011 | $369.4K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $21.18M | +172.3% | +30.4% |
| June 30, 2025 | $16.24M | +101.9% | +9.2% |
| March 31, 2025 | $14.88M | +86.5% | +97.3% |
| December 31, 2024 | $7.54M | -48.0% | -3.1% |
| September 30, 2024 | $7.78M | -53.1% | -3.3% |
| June 30, 2024 | $8.04M | -13.7% | +0.9% |
| March 31, 2024 | $7.98M | -25.7% | -45.0% |
| December 31, 2023 | $14.49M | +51.3% | -12.7% |
- ABVC BIOPHARMA, INC. showed an increase of +179.3% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, ABVC BIOPHARMA, INC.’s total assets has grown by 5601.8% (from $369.4 thousand to $21.06 million).
- The most recent figure is from ABVC BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: